F. Şanlı, N. Barlak, A. Kılınç, Özel Çapık, A. Aytatlı, and O. F. Karatas, “The AKT antagonist AZD5363 suppresses features associated with cancer progression in human larynx cancer cells”, Eur Res J, vol. 6, no. 5, pp. 380–387, Sep. 2020, doi: 10.18621/eurj.624088.